Skip to content
ArgusBio

Provider profile

Enzene.

Biologics CDMOs

Enzene describes cell line, process and formulation development and GMP drug substance manufacturing of monoclonal antibodies and other recombinant proteins from mammalian (CHO) and microbial (E. coli) systems, in fed-batch or continuous mode, with in-house fill and finish of vials, prefilled syringes and cartridges. It lists manufacturing in Chakan (Pune), India, a corporate office in Pune and a New Jersey site.

Website
enzene.com (opens in a new tab)
Sources reviewed
November 3, 2026 · Source pages re-checked within 4 months
First published
November 3, 2026

This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.

Services and capabilities

Services and capabilities

  • Cell line development2,3
  • Formulation development8
  • GMP drug product manufacturing5In-house fill and finish at the Chakan, Pune facility
  • GMP drug substance manufacturing5Stated for the Chakan, Pune manufacturing facility
  • Lyophilization9
  • Process development1
  • Stability studies4

Platforms and methods

  • Mammalian cell culture3,5Proprietary CHO-K1, CHO GS-/- and CHO DHFR-/- host cell lines
  • Microbial fermentation3,5E. coli BL21 bacterial expression platform
  • Single-use bioreactors6Single-use bioreactors with intensified perfusion for continuous upstream processing (EnzeneX platform)

Drug substance / drug product

  • Drug product5
  • Drug substance5

Development experience

Development experience

Development stage

  • Commercial5Stated as commercialized products from the mammalian and microbial manufacturing verticals

Modality

  • Monoclonal antibodies4,7
  • mRNA and nucleic acids3Plasmid DNA only (E. coli DH5α platform; pDNA listed among process development modalities); mRNA not documented
  • Recombinant proteins2

Locations

Locations

  • Pune, India · Headquarters5Described as the corporate office (Bhosari, Pune)
  • Pune, India · Manufacturing site10Chakan Industrial Area: R&D facility plus mammalian and microbial drug substance manufacturing and drug product fill and finish
  • Pennington, United States · Manufacturing site10New Jersey site (Enzene Inc.); the facilities page says it will feature GMP drug substance manufacturing with QC and development laboratories

Quality and regulatory

Quality and regulatory

The provider’s own materials state that it works to, or holds, the following. ArgusBio has not inspected or audited these claims.

  • GMP / cGMP5Stated for the drug substance and fill-finish facilities in India

Unknowns and questions to ask

Unknowns and questions to ask

Public sources rarely establish what matters most for a specific project. Confirm directly:

  • Available capacity, slot timing and scale for your next campaign
  • Recent experience with your specific modality and expression system or chemistry
  • Regulatory inspection history of the specific site that would manufacture your product
  • Technology-transfer approach, timeline and who owns the resulting process knowledge
  • Analytical and QC release testing done in-house versus subcontracted
  • Quality agreement terms, batch-failure responsibility and change-order mechanics

Choosing a CDMO: a practical guide

Evidence and sources

Evidence and sources

  1. 1Process characterization | Enzene (opens in a new tab)Enzene · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  2. 2Process development | Enzene (opens in a new tab)Enzene · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  3. 3Cell line engineering | Enzene (opens in a new tab)Enzene · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  4. 4Home | Enzene (opens in a new tab)Enzene · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  5. 5Facilities | Enzene (opens in a new tab)Enzene · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  6. 6Upstream process development | Enzene (opens in a new tab)Enzene · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  7. 7Cell line development | Enzene (opens in a new tab)Enzene · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  8. 8Formulation and drug product development | Enzene Biosciences (opens in a new tab)Enzene · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  9. 9Drug product manufacturing | Enzene (opens in a new tab)Enzene · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  10. 10Get in touch | Enzene (opens in a new tab)Enzene · Provider website · retrieved November 3, 2026 · last checked November 3, 2026

“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.

Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.

Contact

Contact

Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.

Compare with other biologics cdmos providers

ArgusBio sourcing

Need help evaluating this provider or comparing alternatives.

Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.

Discuss a sourcing need

We work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.